文献速递重症综合管理与镇静镇痛

重症监护中的健康相关生活质量与成本效用分析:一项系统评价

Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论重症成本效用分析在健康相关生活质量测量与方法报告上存在不足,作者认为需标准化测量与报告。

该系统评价检索MEDLINE、Embase等数据库至2020年4月30日,纳入80项成人ICU成本效用分析研究。最常用时间跨度为终身(59%),健康相关生活质量测量率低(29%报告),仅5%报告基线健康相关生活质量;间接效用测量工具使用率85%(多数为EuroQol-5维度,52%)。患者无能力时估算健康相关生活质量的方法少用:插补(19%)、对无能力状态赋固定效用值(19%)、代理人代报(5%)。仅76%研究同时报告增量成本和质量调整生命年,仅34%报告分解的质量调整生命年。

要点

  • 80项成人ICU成本效用分析中,仅29%报告测量了健康相关生活质量,仅5%报告基线健康相关生活质量。
  • 间接效用测量工具使用率85%,其中EuroQol-5维度占52%;最常用时间跨度为终身(59%)。
  • 患者无能力时,插补法用于19%研究,固定效用值赋值用于19%,代理人代报仅5%。
  • 仅76%研究同时报告增量成本与质量调整生命年,仅34%报告分解的质量调整生命年。
  • 作者认为存在不足,需对资源使用、单位成本、健康相关生活质量和方学偏好进行标准化测量与报告。

适用人群与场景

  • 成人重症患者,成人ICU场景;干预:无。

研究设计与关键结果

  • 系统评价共检索8,926条文献,纳入80项成本效用分析研究。
  • 最常用时间跨度为终身(59%)。
  • 健康相关生活质量测量率低(29%报告),仅5%研究报告基线健康相关生活质量。
  • 间接效用测量工具(通用、基于偏好的健康效用测量工具)在85%研究中报告,多数为EuroQol-5维度(52%)。
  • 患者无能力时估算健康相关生活质量的方法少用:插补(19%)、对无能力状态赋固定效用值(19%)、代理人代报(5%)。
  • 仅76%研究同时报告单独的增量成本和质量调整生命年;仅34%研究报告分解的质量调整生命年(分别报告健康效用和生命年)。

证据类型、等级与局限

  • 证据类型:系统评价。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,识别出的不足值得提出建议(对资源使用、单位成本、健康相关生活质量及方法学偏好进行标准化测量与报告),以改进未来重症成本效用分析的设计、实施与报告。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Cost utility analyses compare the costs and health outcome of interventions, with a denominator of quality-adjusted life year, a generic health utility measure combining both quality and quantity of life. Cost utility analyses are difficult to compare when methods are not standardized. It is unclear how cost utility analyses are measured/reported in critical care and what methodologic challenges cost utility analyses pose in this setting. This may lead to differences precluding cost utility analyses comparisons. Therefore, we performed a systematic review of cost utility analyses conducted in critical care. Our objectives were to understand: 1) methodologic characteristics, 2) how health-related quality-of-life was measured/reported, and 3) what costs were reported/measured.

DESIGN: Systematic review.

DATA SOURCES: We systematically searched for cost utility analyses in critical care in MEDLINE, Embase, American College of Physicians Journal Club, CENTRAL, Evidence-Based Medicine Reviews' selected subset of archived versions of UK National Health Service Economic Evaluation Database, Database of Abstracts of Reviews of Effects, and American Economic Association electronic databases from inception to April 30, 2020.

SETTING: Adult ICUs.

PATIENTS: Adult critically ill patients.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Of 8,926 citations, 80 cost utility analyse studies were eligible. The time horizon most commonly reported was lifetime (59%). For health utility reporting, health-related quality-of-life was infrequently measured (29% reported), with only 5% of studies reporting baseline health-related quality-of-life. Indirect utility measures (generic, preference-based health utility measurement tools) were reported in 85% of studies (majority Euro-quality-of-life-5 Domains, 52%). Methods of estimating health-related quality-of-life were seldom used when the patient was incapacitated: imputation (19%), assigning fixed utilities for incapacitation (19%), and surrogates reporting on behalf of incapacitated patients (5%). For cost utility reporting transparency, separate incremental costs and quality-adjusted life years were both reported in only 76% of studies. Disaggregated quality-adjusted life years (reporting separate health utility and life years) were described in only 34% of studies.

CONCLUSIONS: We identified deficiencies which warrant recommendations (standardized measurement/reporting of resource use/unit costs/health-related quality-of-life/methodological preferences) for improved design, conduct, and reporting of future cost utility analyses in critical care.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lau VI, Xie F, Basmaji J, et al. Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review. Crit Care Med. 2021. PMID: 33591013. doi:10.1097/CCM.0000000000004851

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。